671 Phase III study comparing AT (Adriamycin, Docetaxel) to FAC (Fluorouracil, Adriamycin, Cyclophosphamide) as first-line chemotherapy (CT) in patients with metastatic breast cancer (MBC)
作者: M. Bontenbal , J.J. Braun , G.J. Creemers , A.C. de Boer , J.Th.P. Janssen
DOI: 10.1016/S1359-6349(03)90702-6
关键词: